Ianiro, Gianluca
 Distribuzione geografica
Continente #
EU - Europa 5.258
NA - Nord America 4.844
AS - Asia 1.505
SA - Sud America 64
AF - Africa 27
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 10
Totale 11.729
Nazione #
US - Stati Uniti d'America 4.771
DE - Germania 1.737
IT - Italia 1.073
SE - Svezia 888
CN - Cina 601
SG - Singapore 368
IE - Irlanda 313
UA - Ucraina 303
FR - Francia 245
ID - Indonesia 193
GB - Regno Unito 189
PL - Polonia 113
IN - India 110
RU - Federazione Russa 102
FI - Finlandia 101
TR - Turchia 68
CA - Canada 61
BR - Brasile 46
JP - Giappone 34
CZ - Repubblica Ceca 30
NL - Olanda 30
BE - Belgio 28
HK - Hong Kong 28
IR - Iran 26
ES - Italia 24
CH - Svizzera 22
AU - Australia 20
KR - Corea 13
RO - Romania 12
PK - Pakistan 10
AT - Austria 8
CL - Cile 8
GR - Grecia 8
IQ - Iraq 8
TN - Tunisia 8
TW - Taiwan 8
CI - Costa d'Avorio 7
EU - Europa 7
PT - Portogallo 7
VN - Vietnam 6
BY - Bielorussia 5
CO - Colombia 4
CY - Cipro 4
EC - Ecuador 4
HR - Croazia 4
IL - Israele 4
LK - Sri Lanka 4
MX - Messico 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EG - Egitto 3
MY - Malesia 3
AL - Albania 2
BZ - Belize 2
CR - Costa Rica 2
HU - Ungheria 2
JO - Giordania 2
LT - Lituania 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
NO - Norvegia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
YE - Yemen 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 11.729
Città #
Chandler 1.043
Ashburn 396
Dublin 311
Singapore 261
San Mateo 193
Jakarta 191
Ann Arbor 184
Jacksonville 179
Rome 148
Cattolica 145
Wilmington 138
Boston 130
Milan 122
Nanjing 121
Nürnberg 121
New York 119
Woodbridge 100
Fairfield 98
Marseille 94
Beijing 89
Princeton 86
Warsaw 81
Houston 79
Moscow 79
Redwood City 79
Lawrence 64
Chicago 62
Dearborn 62
Boardman 61
Izmir 56
Los Angeles 54
Seattle 54
Las Vegas 38
Nanchang 38
Hangzhou 36
Cambridge 35
Leawood 33
Pune 33
Munich 32
Brussels 26
Shenyang 26
Augusta 24
Bremen 24
London 24
Redmond 24
Shanghai 24
Norwalk 23
Hebei 22
Helsinki 22
Hong Kong 21
Tianjin 21
Mountain View 20
Trieste 20
Zhengzhou 20
Changsha 19
Jiaxing 17
Kraków 17
University Park 17
Washington 17
Andover 16
Fremont 16
Kunming 16
Lancaster 15
Ottawa 15
Falls Church 14
Verona 14
Bologna 13
Padova 13
Kish 12
Brno 11
Lappeenranta 11
Melbourne 11
Naples 11
Toronto 11
Guangzhou 10
Seoul 10
Busto Arsizio 9
Edinburgh 9
Genoa 9
Porto Alegre 9
Zurich 9
Abidjan 7
Detroit 7
Ferrara 7
Hefei 7
Jinan 7
Lanzhou 7
Monmouth Junction 7
San Diego 7
San Francisco 7
Simi Valley 7
Tokyo 7
Xian 7
Atlanta 6
Ceska 6
Chengdu 6
Karachi 6
San Jose 6
Staten Island 6
Berlin 5
Totale 6.062
Nome #
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 376
From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance 277
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 251
Wheat desensitization treatment in patients with gluten sensitivity 201
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 190
The role of intestinal microbiota and the immune system 178
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 177
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 174
The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial 160
White mulberry supplementation as adjuvant treatment of obesity 156
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 154
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics 153
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 153
The role of diet on gut microbiota composition 148
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 138
Gut microbiota in autism and mood disorders 135
Nutritional aspects of Helicobacter pylori infection 133
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 132
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 131
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 130
13C-octanoic acid breath test to study gastric emptying time 129
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 128
Can chronic gastritis cause increase of fecal calprotectin concentrations? 126
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 123
Fecal microbiota transplantation: Past, present and future perspectives 123
Assessment of neurological manifestations in hospitalized patients with COVID-19 116
Gut microbiota in autism and mood disorders 114
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 113
Role of gut microbiota in food tolerance and allergies 110
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 108
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 107
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection 102
Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features 99
Moderately Severe Acute Pancreatitis Associated With Riluzole 98
Microscopic colitis 97
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 95
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 92
Gut microbiota and metabolic syndrome 91
Coeliac disease: an old or a new disease? History of a pathology 91
Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. 91
Current technologies for the endoscopic assessment of duodenal villous pattern in celiac disease 91
Role of N-acetyl-cisteine in the treatment of H. pylori 90
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 90
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 88
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 88
European consensus conference on faecal microbiota transplantation in clinical practice 86
Autism, gastrointestinal symptoms and modulation of gut microbiota by nutritional interventions 86
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 85
Detection of rare G3P[19] group A rotavirus in human patient, Italy 85
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases 84
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 82
Levothyroxine absorption in health and disease, and new therapeutic perspectives 81
Gut microbiome, big data and machine learning to promote precision medicine for cancer 81
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center 79
Pancreatic function assessment 78
The role of biomarkers in diverticular disease 77
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 72
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review 71
Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients 71
Barrett's oesophagus and associated dysplasia are not equally distributed within the esophageal circumference 71
Gut microbiota and inflammatory bowel disease: an update 71
A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial 71
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 69
Ipilimumab Adjuvant Therapy in Melanoma 68
Culture-guided treatment approach for Helicobacter pylori infection: review of the literature 67
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 67
The human gut microbiota and virome: Potential therapeutic implications 65
The facts about food after cancer diagnosis: A systematic review of prospective cohort studies 65
Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota 64
Helicobacter pylori in metabolic related diseases 61
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome 59
How to define a quadruple aim framework to assess value in critical pathway of the patients with Clostridioides difficile infection 58
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 56
Bacillus clausii for the treatment of acute diarrhea in children: A systematic review and meta-analysis of randomized controlled trials 55
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 55
Gut Virome and Inflammatory Bowel Disease 54
Digestive Enzyme Supplementation in Gastrointestinal Diseases 54
Modulation of gut microbiota in patients with IBS and systemic nickel allergy after diet and probiotic supplementation: a pilot study 54
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 54
Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement 53
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 53
The gut microbiota: its anatomy and physiology during all life 52
From Regular Catharsis with Castor Oil to Recognizing the Importance of the Intestinal Microbiota 52
Omega-3 fatty acids: a novel resort against gastrointestinal injury 51
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update 51
Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? 50
Gastroenterology training in Europe: unmet educational needs beyond the machines 50
Antibiotics as deep modulators of gut microbiota: Between good and evil 50
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients 50
FECAL CALPROTECTIN AND NEED OF MULTIPLE MICROBIOTA TRANSPLANTATION INFUSIONS IN CLOSTRIDIUM DIFFICILE INFECTION 49
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 49
Gastric Microbiota 48
Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome 48
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 47
Oral supplementation with lactobacilli to prevent colorectal cancer in preclinical models 47
Diet-Induced Alterations in Gut Microbiota Composition and Function 47
Endoscopic tools for the diagnosis and evaluation of celiac disease 46
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 46
Laboratory handling practice for faecal microbiota transplantation 46
Endoscopic tools for the diagnosis and evaluation of celiac disease 45
Totale 9.533
Categoria #
all - tutte 53.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020983 0 0 72 95 96 115 147 58 92 65 145 98
2020/20211.147 62 121 29 97 140 97 124 26 120 80 196 55
2021/20221.358 77 77 37 77 92 66 41 217 55 81 271 267
2022/20233.069 404 384 225 436 185 372 152 266 371 81 109 84
2023/20241.994 99 478 93 110 86 270 169 92 53 107 207 230
2024/2025584 118 152 314 0 0 0 0 0 0 0 0 0
Totale 11.997